Litcius/Paper detail

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial

Sylke Haal, Maimoena S S Guman, Thomas C C Boerlage, Yair I Z Acherman, L Maurits de Brauw, Sjoerd Bruin, Steve M M de Castro, Jeanin E van Hooft, Arnold W J M van de Laar, Daan E Moes, Manon Schouten, Ruben Schouten, Ellert J van Soest, Ruben N van Veen, Claire E E de Vries, Paul Fockens, Marcel G W Dijkgraaf, Victor E A Gerdes, Rogier P Voermans

2021˜The œLancet. Gastroenterology & hepatology71 citationsDOIOpen Access PDF

Topics & Concepts

MedicineUrsodeoxycholic acidDiseaseSurgeryClinical trialInternal medicineGeneral surgeryGastroenterologyDiabetes mellitusEpidemiologyMEDLINEBariatric Surgery and OutcomesGallbladder and Bile Duct DisordersDrug Transport and Resistance Mechanisms
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial | Litcius